INTERFERONS, INTERLEUKIN-2 AND TUMOR-NECROSIS-FACTOR - NEW APPROACHES TO CANCER-THERAPY

被引:0
|
作者
OETTGEN, HF
机构
来源
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 1987年 / 37-1卷 / 2A期
关键词
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:251 / 255
页数:5
相关论文
共 50 条
  • [1] INTERFERONS, INTERLEUKIN-2, AND TUMOR-NECROSIS-FACTOR - NEW BEGINNING IN TUMOR-THERAPY
    GALLMEIER, WM
    BRUNTSCH, U
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1986, 128 (14): : 251 - 252
  • [2] THE CURRENT USE OF INTERFERONS, INTERLEUKIN-2 AND TUMOR-NECROSIS-FACTOR IN RENAL-CELL CANCER
    WIRTH, M
    UROLOGIA INTERNATIONALIS, 1991, 47 (04) : 219 - 230
  • [3] PRIMING EFFECT OF INTERFERONS AND INTERLEUKIN-2 ON ENDOGENOUS PRODUCTION OF TUMOR-NECROSIS-FACTOR IN MICE
    SATOH, M
    SHIMADA, Y
    INAGAWA, H
    MINAGAWA, H
    KAJIKAWA, T
    OSHIMA, H
    ABE, S
    YAMAZAKI, M
    MIZUNO, D
    JAPANESE JOURNAL OF CANCER RESEARCH, 1986, 77 (04): : 342 - 344
  • [4] TUMOR-NECROSIS-FACTOR ACTIVITIES AND CANCER-THERAPY - A PERSPECTIVE
    SIDHU, RS
    BOLLON, AP
    PHARMACOLOGY & THERAPEUTICS, 1993, 57 (01) : 79 - 128
  • [5] INTERLEUKIN-2 IN CANCER-THERAPY
    PARKINSON, DR
    SEMINARS IN ONCOLOGY, 1988, 15 (06) : 10 - 26
  • [6] INTERLEUKIN-2 AND CANCER-THERAPY
    HANCOCK, BW
    REES, RC
    CANCER CELLS-A MONTHLY REVIEW, 1990, 2 (01): : 29 - 32
  • [7] COMPLICATIONS OF INTERLEUKIN-2 CANCER-THERAPY
    MITTELMAN, A
    GAFNEY, E
    INFECTIONS IN SURGERY, 1990, 9 (08): : 9 - &
  • [8] THE ROLE OF INTERLEUKIN-2 IN CANCER-THERAPY
    KOHLER, PC
    SONDEL, PM
    CANCER SURVEYS, 1989, 8 (04) : 861 - 873
  • [9] TUMOR-NECROSIS-FACTOR, INTERLEUKIN-2, AND INTERFERON-GAMMA IN ADULT VARICELLA
    WALLACE, MR
    WOELFL, I
    BOWLER, WA
    OLSON, PE
    MURRAY, NB
    BRODINE, SK
    OLDFIELD, EC
    ARVIN, AM
    JOURNAL OF MEDICAL VIROLOGY, 1994, 43 (01) : 69 - 71
  • [10] INTERLEUKIN-2 INDUCES TUMOR-NECROSIS-FACTOR GENE-EXPRESSION INVIVO
    REMICK, DG
    NGUYEN, DT
    ESKANDARI, MK
    KUNKEL, SL
    IMMUNOLOGICAL INVESTIGATIONS, 1991, 20 (04) : 395 - 405